Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis

Ophthalmology. 2018 Sep;125(9):1468-1471. doi: 10.1016/j.ophtha.2018.03.004. Epub 2018 Apr 10.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Humans
  • Keratitis / drug therapy*
  • Male
  • Middle Aged
  • Nerve Growth Factors / administration & dosage*
  • Ophthalmic Solutions
  • Recombinant Proteins / administration & dosage*
  • Treatment Outcome
  • Trigeminal Nerve Diseases / drug therapy*

Substances

  • Nerve Growth Factors
  • Ophthalmic Solutions
  • Recombinant Proteins